Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin oral solution for burning mouth syndrome
IRCT20220117053748N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of capsaicin in glossodynia (BMS) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Improvement of burning mouth. Started Feb 2022; status: completed.
02
Drugs
capsaicin
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on IRCT20220117053748N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220117053748N1.